Search Results

Evaluation of ovarian functions in girls treated for hematological malignancy

• Authors : Şule Çalışkan Kamış; Begül Yağcı; Ayşe Selcan Koç

Subjects: AMH; Inhibin-B; Ovarian follicle count

• Source: Scientific Reports, Vol 15, Iss 1, Pp 1-9 (2025)

Record details

MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphoma

• Authors : Kyung Ju Ryu; Haein Ji; Bon Park

Subjects: PD-L1; miR-340-5p; NK/T-cell Lymphoma

• Source: Scientific Reports, Vol 15, Iss 1, Pp 1-9 (2025)

Record details

Immune signature and pathways investigation of adrenal gland diffuse large B-cell lymphoma

• Authors : Weijing Jia; Ruochen Qi; Xiaoyan Zhang

Subjects: DLBCL; Adrenal gland; RNAseq

• Source: Scientific Reports, Vol 15, Iss 1, Pp 1-8 (2025)

Record details

Illuminating the impact of CD38-induced adenosine formation in B-cell lymphoma

• Authors : Shams ElDoha Galal ElDin Zaiema; Heba Mohamed Saber Hafez; Diaa El-Din Moussa Sherif Abou El-Ela

Subjects: CD38 expression; Extracellular ADO; Mature B-cell lymphoma

• Source: Scientific Reports, Vol 15, Iss 1, Pp 1-15 (2025)

Record details

Survival of HIV associated diffuse large B-cell lymphoma and Burkitt lymphoma in China.

• Authors : Xiong Y; Department of Radiation and Medical Oncology for Esophageal Mediastinal and Lymphatic Tumors, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.

Subjects: Burkitt Lymphoma*/Burkitt Lymphoma*/Burkitt Lymphoma*/mortality ; Burkitt Lymphoma*/Burkitt Lymphoma*/Burkitt Lymphoma*/drug therapy ; Burkitt Lymphoma*/Burkitt Lymphoma*/Burkitt Lymphoma*/epidemiology

• Source: Scientific reports [Sci Rep] 2024 Dec 05; Vol. 14 (1), pp. 30397. Date of Electronic Publication: 2024 Dec 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Author Correction: Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma.

• Authors : Menéndez V; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.; Solórzano JL

• Source: Scientific reports [Sci Rep] 2024 Nov 11; Vol. 14 (1), pp. 27537. Date of Electronic Publication: 2024 Nov 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study.

• Authors : Wang Y; Department of Research and Foreign Affairs, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.; Cai Y

Subjects: Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/radiotherapy ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/epidemiology ; Neoplasms, Second Primary*/Neoplasms, Second Primary*/Neoplasms, Second Primary*/epidemiology

• Source: Scientific reports [Sci Rep] 2024 Oct 19; Vol. 14 (1), pp. 24623. Date of Electronic Publication: 2024 Oct 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Trends in 5-year cancer survival disparities by race and ethnicity in the US between 2002-2006 and 2015-2019.

• Authors : Chen C; Pancreas Center, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu, People's Republic of China.

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/mortality ; Neoplasms*/Neoplasms*/Neoplasms*/ethnology ; SEER Program*

• Source: Scientific reports [Sci Rep] 2024 Sep 30; Vol. 14 (1), pp. 22715. Date of Electronic Publication: 2024 Sep 30.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Antibody-drug conjugates and immune checkpoint inhibitors in cancer treatment: a systematic review and meta-analysis.

• Authors : Zhang L; Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Hangzhou, China.; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/therapeutic use

• Source: Scientific reports [Sci Rep] 2024 Sep 27; Vol. 14 (1), pp. 22357. Date of Electronic Publication: 2024 Sep 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Adult Hodgkin lymphoma incidence trends in the United States from 2000 to 2020.

• Authors : Aslani A; Department of Community Medicine, Faculty of Medicine, Social Determinants of Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.; Morsali S

Subjects: Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/epidemiology; Humans ; United States/United States/United States/epidemiology

• Source: Scientific reports [Sci Rep] 2024 Sep 03; Vol. 14 (1), pp. 20500. Date of Electronic Publication: 2024 Sep 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details